124 related articles for article (PubMed ID: 32992030)
1. Ethnic influence on the phenotype of French patients with systemic sclerosis.
Steelandt A; Benmostefa N; Avouac J; Mouthon L; Allanore Y
Joint Bone Spine; 2021 Mar; 88(2):105081. PubMed ID: 32992030
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Venezuelan patients with systemic sclerosis: a study in a tertiary hospital in Caracas.
Rivas-Vargas D; Snih SA; Rodríguez MA
Reumatol Clin (Engl Ed); 2021 Dec; 17(10):601-606. PubMed ID: 34823828
[TBL] [Abstract][Full Text] [Related]
3. Systemic sclerosis patients with negative antinuclear antibodies have distinctive clinical manifestations: a multicenter CRDC cohort in China.
Hui M; Wang X; Zhou J; Zhang L; Duan X; Li M; Wang Q; Zhao J; Hou Y; Xu D; Zeng X
Z Rheumatol; 2024 Feb; 83(Suppl 1):160-166. PubMed ID: 35852599
[TBL] [Abstract][Full Text] [Related]
4. Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohort.
Jung M; Bonner A; Hudson M; Baron M; Pope JE;
Scand J Rheumatol; 2014; 43(3):217-20. PubMed ID: 24650305
[TBL] [Abstract][Full Text] [Related]
5. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
[TBL] [Abstract][Full Text] [Related]
6. Ethnic Variations in Systemic Sclerosis Disease Manifestations, Internal Organ Involvement, and Mortality.
Al-Sheikh H; Ahmad Z; Johnson SR
J Rheumatol; 2019 Sep; 46(9):1103-1108. PubMed ID: 30824634
[TBL] [Abstract][Full Text] [Related]
7. Lung involvement in systemic sclerosis (scleroderma): relation to classification based on extent of skin involvement or autoantibody status.
Kane GC; Varga J; Conant EF; Spirn PW; Jimenez S; Fish JE
Respir Med; 1996 Apr; 90(4):223-30. PubMed ID: 8736656
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications.
Ghizzoni C; Sebastiani M; Manfredi A; Campomori F; Colaci M; Giuggioli D; Ferri C
Microvasc Res; 2015 May; 99():92-5. PubMed ID: 25842153
[TBL] [Abstract][Full Text] [Related]
9. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
[TBL] [Abstract][Full Text] [Related]
10. [Clinical features of systemic sclerosis and association with antitopoisomerase-1 antibody and centromere pattern of antinuclear antibody].
Bertazzi GR; de Toledo RA; de Godoy MF; Geraldino GC; Polizelli DV; Fernandes GC; Pedroso CL; dos Santos FG; de Assis TM
Acta Reumatol Port; 2012; 37(1):9-17. PubMed ID: 22781510
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the clinical phenotype of systemic sclerosis patients in Iran and France in two university centers.
Allanore Y; Gharibdoost F; Jamshidi AR; Javinani A; Avouac J; Rastkar E; Hooshmandi S; Kavosi H
J Scleroderma Relat Disord; 2019 Jun; 4(2):149-159. PubMed ID: 35382390
[TBL] [Abstract][Full Text] [Related]
12. Investigation of prognostic factors for skin sclerosis and lung function in Japanese patients with early systemic sclerosis: a multicentre prospective observational study.
Hasegawa M; Asano Y; Endo H; Fujimoto M; Goto D; Ihn H; Inoue K; Ishikawa O; Kawaguchi Y; Kuwana M; Muro Y; Ogawa F; Sasaki T; Takahashi H; Tanaka S; Takehara K; Sato S
Rheumatology (Oxford); 2012 Jan; 51(1):129-33. PubMed ID: 22072085
[TBL] [Abstract][Full Text] [Related]
13. Clinical correlates of CENP-A and CENP-B antibodies in a large cohort of patients with systemic sclerosis.
Hudson M; Mahler M; Pope J; You D; Tatibouet S; Steele R; Baron M; ; Fritzler M
J Rheumatol; 2012 Apr; 39(4):787-94. PubMed ID: 22467948
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
[TBL] [Abstract][Full Text] [Related]
15. A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement.
Trombetta AC; Soldano S; Contini P; Tomatis V; Ruaro B; Paolino S; Brizzolara R; Montagna P; Sulli A; Pizzorni C; Smith V; Cutolo M
Respir Res; 2018 Sep; 19(1):186. PubMed ID: 30249259
[TBL] [Abstract][Full Text] [Related]
16. Incidence and predictors of interstitial lung disease (ILD) in Thai patients with early systemic sclerosis: Inception cohort study.
Wangkaew S; Euathrongchit J; Wattanawittawas P; Kasitanon N; Louthrenoo W
Mod Rheumatol; 2016 Jul; 26(4):588-93. PubMed ID: 26561397
[TBL] [Abstract][Full Text] [Related]
17. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O
J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258
[TBL] [Abstract][Full Text] [Related]
18. Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature.
Ferri C; De Angelis R; Giuggioli D; Bajocchi G; Dagna L; Zanframundo G; Foti R; Cacciapaglia F; Cuomo G; Ariani A; Rosato E; Guiducci S; Girelli F; Riccieri V; Zanatta E; Bosello S; Cavazzana I; Ingegnoli F; De Santis M; Murdaca G; Abignano G; Romeo N; Della Rossa A; Caminiti M; Iuliano A; Ciano G; Beretta L; Bagnato G; Lubrano E; De Andres I; Giollo A; Saracco M; Agnes C; Lumetti F; Spinella A; Magnani L; Campochiaro C; De Luca G; Codullo V; Visalli E; Masini F; Gigante A; Bellando-Randone S; Pellegrino G; Pigatto E; Lazzaroni MG; Franceschini F; Generali E; Mennillo G; Barsotti S; Mariano GP; Calabrese F; Furini F; Vultaggio L; Parisi S; Peroni CL; Rozza D; Zanetti A; Carrara G; Landolfi G; Scirè CA; Bianchi G; Fusaro E; Sebastiani GD; Govoni M; D'Angelo S; Cozzi F; Doria A; Iannone F; Salvarani C; Matucci-Cerinic M;
Autoimmun Rev; 2022 Oct; 21(10):103159. PubMed ID: 35908642
[TBL] [Abstract][Full Text] [Related]
19. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis.
Meyer OC; Fertig N; Lucas M; Somogyi N; Medsger TA
J Rheumatol; 2007 Jan; 34(1):104-9. PubMed ID: 17117486
[TBL] [Abstract][Full Text] [Related]
20. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.
Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ;
Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
